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Moving from chaos to hope: key factors influencing the narratives of people taking opioids for 
chronic non-cancer pain 
 
ABSTRACT  
Aims 
To investigate the progression of the illness and opioid journeys of people who are taking opioids for 
chronic non-cancer pain. 
Methods 
In depth qualitative interviews were conducted with 20 people who were taking opioids for non-cancer 
pain. A purposive sample was drawn from patients attending two pain clinics in Melbourne, Australia. 
Transcripts were analysed within-case, as individual narratives, and across-case, as a thematic 
analysis. Conceptual explanatory variables were developed. 
Results 
The experience of taking opioids for chronic non-cancer pain varies greatly between individuals and 
these diverse narratives – chaos, restitution and quest narratives- raise questions about why and how 
some individuals find a way forward, whilst others remain in situations of chaotic and worsening ill 
health. We offer an explanation for this variability in terms of four key influences: support from 
individual health professionals and the health system; medical explanation or solutions; social support 
and social responsibilities; and the use of non-pharmaceutical interventions and self-help strategies. A 
unifying theme was the importance of maintaining hope. 
Conclusion 
The four key factors influencing the progress of people taking opioids for chronic non-cancer pain 
are rooted in the provisions made by society for caring for this patient group and involve relationships 
between patient and provider, between patients and their social world, and between different 
providers and their professional knowledge. In our patient sample, effective support involved the 
provision and maintenance of hope, and professionals who are knowledgeable about opioids and 
chronic pain, good communicators, and cognisant with their patients’ social support and 
responsibilities. 
Key words:  
opioids, chronic pain, qualitative research, patients’ experience, support, hope 
 
50 words summary 
This paper describes a qualitative study in which patients taking opioid medications for chronic non-
cancer pain were interviewed for their experience of using these medications. We identified three 
patterns of experience and illustrated the importance of support, hope and access to specialist and 
complementary services.  
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INTRODUCTION 
The use of opioid medications in the treatment of chronic non-cancer pain is increasing worldwide.
(1)
 
For example in South Australia the number of patients on extended opioid treatment for chronic pain 
has increased about 10 fold over 15 years.
(2) 
The data are consistent with the results released by the 
International Narcotic Control Board. From 1980 to 2005, the use of morphine has increased by eight 
times and Oxycodone by 20 times in Australia
(3)
 and increased by 40 and 20 times in the United 
States in America, respectively.
(4)
 Surveys examining clinicians’ views about this treatment modality 
mainly focus on fears of opioid over-use or diversion
(5)
 and this approach is mirrored in clinical 
guidelines. For example guidelines from the Royal Australasian College of Physicians state that two 
of the goals are to standardise “regulatory strategies”, to reduce opioid dependence and to reduce 
“the diversion of pharmaceutical opioids on to the black market.”
(6)
 In depth qualitative studies of 
primary care providers, however, suggest a more complex range of concerns that include not only 
those of addiction and misuse but also patient resistance to taking opioids, potential harm from 
adverse effects (especially in the elderly) and inadequate training of providers.
(7)
 In-depth studies of 
the patients’ perspectives are rare, and mainly focus on those who experience good relief with opioid 
medications.
(8-10) 
Their findings suggest that patients’ concerns and experiences differ somewhat from 
those of health professionals. Patients focus on their experiences of balancing the perceived benefits 
of less severe pain and better functioning against the associated stigma, medication side effects and 
difficulties of maintaining access to the regime.
(8-10)
 Overall, this diverse literature suggests that taking 
opioids for chronic non-cancer pain is increasingly common and has the potential for substantial relief 
of suffering but that it is also fraught with difficulties and dangers. As such it is a fruitful topic for 
further research into the factors that influence the balance between benefit and harm. 
 
We sought to build on previous qualitative studies by interviewing patients who were attending pain 
management clinics in Australia with chronic non-cancer pain and by including some people who had 
expressed interest in reducing their opioid medication. We anticipated that this sample would provide 
experiences from a range of users including those with a long history of opioid use, those 
experiencing difficulties with pain management despite specialist input, and those that were stabilising 
or improving with such input. We aimed to analyse their opioid and illness journeys over time and to 
elucidate the factors that influenced the progression of these journeys. By this means we hoped to be 
able to make links between the patient and provider perspectives and produce findings with clinical 
relevance.  
 
 
METHODS 
In order to gain an in depth understanding of individual patient experiences and perceptions we used 
qualitative individual interviews.
(11)
 Ethical approval was obtained from Alfred Health, Melbourne 
Health and RMIT University and data collection was carried out between July 2010 and February 
2011.  
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Six researchers with a variety of medical and social science experience and perspectives were 
involved in developing the sampling frame, the interview schedule, and / or the coding categories and 
the final analysis was discussed with clinicians in the participating pain clinics. 
Setting and sampling strategy. 
The study ran alongside a clinical trial which was investigating the use of electroacupuncture and 
education to reduce opioid medication by people with chronic non-cancer pain. We drew a purposive 
sample of people taking opioids for chronic non-cancer pain from three groups: a) patients taking part 
in the trial, b) patients who had been approached but declined to take part in the trial, and c) patients 
who had not been approached for the trial. Twenty eight potential study participants were approached 
by researchers by letter and/or telephone until 20 patients with a range of age, sex and duration of 
condition had been interviewed. One could not be interviewed for not on opioids any more, two 
declined because of living too far, two being too busy, and three without providing any reasons. The 
20 participants were made up of 13 from group a), one from group b) and six from group c). In this 
paper, Group a was coded as trial patients; whereas Groups b and c were non-trial patients. 
Data collection 
KL, a researcher with a background in psychology, carried out semi-structured interviews, of 30-80 
minutes duration, in people’s homes or, if they preferred, at the clinics, or in an independent research 
institute. KL was supervised by CP, an xperienced qualitative researcher, and a constant 
comparative approach was used, in which data analysis went side-by-side with data collection, thus 
enabling later interviews to explore emerging themes.
(12)
 The interview began with an open question 
asking for some background to their current situation and then used prompts and questions to 
understand their experiences up to the present day. This included enquiry into their illness and 
disability, treatments, details of opioid use and life-world context. See Appendix for initial interview 
schedule. The interviews were audio-recorded and transcribed verbatim. 
Data analysis 
N-Vivo software was used to organise the data. Three researchers developed an inductive coding 
framework of descriptive themes, resolving differences by discussion and by attending to reflexivity 
and our own differing perspectives. All the data in all the interviews was then coded and during this 
process analytic memos were written and discussed and matrices were used to look for relationships 
between themes and patient characteristics. Negative cases were explored and used to deepen the 
analysis so that all cases were explained by it.  
The accounts were also summarised as individual illness narratives
(13, 14)
 within which the threads of 
illness and disability interwove over time with the circumstances and effects of prescribed opioid 
medications and with social roles and responsibilities.
(15)
 Each temporal narrative was depicted 
diagramatically as an ‘opioid journey’ that took place alongside the individual ‘illness journey’ (see 
Figures 1,2,3 for examples). These temporal narratives demonstrated considerable diversity and we 
characterised the diversity by identifying a range of narrative categories or genres.
(14)
 Gergen & 
Gergen (1983)
(16)
 suggest that narratives may be classified into three fundamental or core types: 
stability narratives, progressive narratives and regressive narratives, whereas others use genres that 
are culturally available and familiar, such as tragedy, epic quest, romance and comedy.
(17)
 However, 
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we found the categories that best suited our data were those used by Frank (1995):
(18)
 chaos, 
restitution and quest. Chaos narratives are those where the individual imagines she or he will never 
get better. Restitution narratives are those that involve the expectation that the sufferer will become 
healthy again. Quest narratives are those that involve self-transformation and the offering of help to 
themselves and others through illness. These basic types become linked in various ways to make 
more complex accounts that span many years of experience. 
In this study the process of categorising the narratives in these ways generated second-order 
constructs that were compared with the themes from the thematic analysis. As the analysis continued, 
we considered how these themes and constructs helped us to explain the diversity of patient 
narratives –what factors were important in the movement out of chaos into restitution or quest? In this 
paper we present a brief summary of the range of narrative genres and present in more detail the four 
explanatory conceptual themes. Details of the participant’s medicine taking behaviour are reported 
elsewhere. 
 
FINDINGS 
The twenty participants are summarised in Table 1: 10 each of men and women, an age range of 29 – 
77 years (Mean ± SD: 52 ±12.5) and 19 were white Australian ethnicity and one being African origin.   
Ten out of 20 participants were treated for low back pain, three for fibromyalgia, two neck pain, two 
pain after amputation, and one each for hip pain, burn pain and facial pain. Nine of 20 participants 
had opioid medications for three years or less, five had between three to 10 years and six over 10 
years. The types of opioids varied from transdermal patches, slow release types, such as OxyContin, 
to short acting ones, such as Endone.  
Narrative analysis 
The opioid journeys described above spanned many years of illness during which the circumstances 
and effects of prescribed opioid medications interwove with threads of illness and disability and social 
roles and responsibilities. Over these years some people had experienced periods when they had 
found some sense of balance, control, and quality of life, whereas others hadn’t. They were all stories 
in the making, being told at one point in an ongoing journey, but their diversity can be described in 
terms of three fundamental narrative categories: chaos, restitution and quest. Chaos narratives are 
those where the individual imagines she or he will never get better and all the narratives were at some 
point, usually near the beginning, chaos narratives i.e. they were characterised by worsening and 
chaotic pain and/or opioid related problems and periods of hopelessness. Whilst eight accounts 
remained overall as chaos throughout their time-span, others moved into a more hopeful restitution 
narrative – where positive expectation and action led to some stabilisation or reduction of pain and 
opioid use. We labelled the five accounts that moved from chaos to a more active and stable situation 
as restitution narratives. The remaining seven narrators indicated a further degree of progression that 
included a degree of adaptation and successful coping with or without continuing slow improvement in 
pain control. We labelled these quest narratives as they involved degrees of self-transformation and 
the offering of help to themselves and others through illness. Most of this group were slowly reducing 
their opioids or had stabilised on a lower dose and their previous severe side effects were lessened. 
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Figures 1,2 and 3 provide an example of each of these genres. In this paper we report our analysis of 
the factors that influence, for better or worse, the experience of pain and opioid use in the chaos 
narratives and the complex roles these factors play in promoting the progression into a more stable 
and hopeful position of restitution or quest. 
 
The analysis indicated that the most influential factors were: support from individual health 
professionals and the health system; medical explanation or solution; social support and social 
responsibilities; and the use of non-pharmaceutical interventions and self-help strategies. None of 
these were a single defining factor in moving forward out of chaos but together they encompass the 
range of influences and potential interventions that may prove helpful to people taking opioids for 
chronic pain. There was no evidence that age, sex, or whether or not participants were recruited from 
the trial had an influence on the illness trajectory. In this section we will start by describing how these 
narratives of opioid use for chronic pain began and then address each of the key factors that 
influenced how they proceeded. 
 
Starting opioids 
Starting opioids was often an insidious rather than a dramatic event and few participants foresaw the 
long-term nature of the journey ahead. Eleven participants had their first prescription for opioids from 
their general practitioner (GP). Generally this was a lower dose preparation such as Panadeine or 
tramadol but sometimes stronger opioids such as Kapanol, Endone or Oxycontin were prescribed on 
the basis of advice from a specialist. The decision to start taking low dose opioids was often 
perceived as routine at the time and some people had taken such medication for short periods in the 
past.  
 I started off on Panadeine Forte like you know you, like normal people I guess would start on just 
Panadeine Forte and of course that, you know didn’t, started losing you know the - you know 
started not working, so they went to something stronger [Susan]  
 
Similarly, Max had first taken Panadeine Forte after a knee operation over ten years ago and ’was off 
that in a week’ but when he was prescribed it again after an accident it made him feel sick so he 
returned to his GP who ‘said we’ll switch over to something else and I think he gave me 5mg ones or 
something like that of the Oxycontin’. 
 
Sometimes Panadeine was prescribed immediately following an injury or sudden pain but more often 
it followed on a period of investigation or other medication: “he diagnosed it as fibromyalgia and it was 
then that he put me on the Kapanol” [Ella]; “They weren’t able to do any more apart from keeping the 
back moving so hence the medication” [Jack]; “none of it did any good for me and so I finally came 
down to using a bit of the Oxycontin stuff” [Oliver].In these instances opioids were again experienced 
as a natural next step, albeit as an option of last resort in a situation fraught with persistent pain and 
uncertainty. However, several participants took a more active role and refused to take opioids for 
many months because of concerns about addiction and adverse effects. This included Rose who 
resisted taking oxycontin until ‘the pain made up its mind for me’; Anna, who went through two pain 
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management courses before the pain clinic doctors persuaded her to take Tramadol and Eve ,who 
was seeing her GP: 
 I just didn’t want to go on them because I mean once you get on them that’s it, you’re sort of stuck on 
them. I didn’t want to take morphine at first because there was a girl that I went through one of the 
courses with and she always seemed really dopey and drugged up so it took them a long while to talk 
me to into taking the morphine because I didn’t want to be like that [Anna] 
 
“I refused all pain medication for about six months but then the condition got worse and in the end I 
just, yeah, I couldn’t go without it” [Eve] 
 
A very strong theme throughout Eve’s account was that she had been raised to believe that she 
should not use medication to control pain. Rose, Anna and Eve all continued to be active in seeking 
alternatives to opioids and their accounts were categorised as restitution or quest narratives. 
 
The other common scenario for starting opioids was a dramatic hospital admission for trauma or for 
major surgery. In these instances patients were either very ill or were undergoing major operations 
such as amputations and were not aware of the details of their medication.  
“I was out of it, so I basically woke up two weeks later with a drip of morphine and ketamine in my 
arm going ‘What’s going on?”  [Lucy] 
 
“ The thoracotomy was a big operation, so I was always having - you’re having your - the nurses 
coming in every hour or whatever to take all your level - readings and that sort of thing and then 
you’ve got different people coming to see you.  You're having so many things going on that it’s all 
a bit of a blur and you don’t really get to understand details of the pain medication” [Tom] 
 
Two participants described another dramatic start to taking opioids in the form of repeated pethidine 
or morphine injections from the accident and emergency department “because I couldn’t take the pain 
anymore” [William] - both of these were eventually prescribed Panadeine by their GPs. 
 
Four factors influencing the narratives   
1. Support from individual health professionals and the health system 
The arena of opioid treatment for chronic pain is inevitably highly medicalised and participants’ 
accounts indicated that the degree and type of support they received from health professionals, 
especially their prescribing doctor, were of great importance. The aspects of support that were most 
valued were a sound knowledge base about opioid medication and pain management; good 
communication skills; and the maintenance of hope. Many of the accounts described an unmet desire 
and need for such support. Claire described two very different experiences at the pain management 
clinic: 
The first guy, he gave me no will. I walked out going “I might as well be dead. I’m never going to…” 
He goes “You’re going to live with this pain for the rest of your life.” And I go “I may as well just go 
home and kill myself. I’ve got no motivation to do it.” He gave me no positives for living, where 
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when I come back the next time, I got G. She was wonderful, you know. She says “All right. We 
may not be able to get rid of it completely. But we should be – hopefully be able to manage it for 
you a lot better than what it is.” And that’s all I wanted to hear.” [Claire] 
Rose also described a variety of experiences with different doctors and viewed her change of GP as 
‘the best thing I’ve ever done’ and as instrumental in her success in coming off opioids. She 
particularly valued good communication and access: 
 I know I could ring up my doctor and, or email him and ask him a question.  So, it wasn’t as if, as if 
– and the pain clinic, I was happy with them as well. [Rose]  
Tom valued his GP’s style of shared decision making in relation to his opioid medication: 
He’s, he’s - well, I wouldn’t say he’s enthusiastic, but he’s helpful when - or he’s encouraging to - 
me to lower the levels when - when pain permits, so he asks me how the pain’s going and then he 
says do you want to drop down a level and - or I’ll suggest to him, either way, but no, he’s, my 
GP’s really good.[Tom] 
A number of participants found that the pain clinic professionals were particularly helpful and were 
able to give them time to learn to accept their enduring illness and the need for medication. For these 
people the pain clinic counteracted previous feelings of isolation by providing a range of therapies and 
a sense of being ‘the same as someone else’.  
Yeah because I went through two courses through here and they’re very good, they explain 
everything, and I mean they explain how to do meditation and all other sort of things to try and help 
you as well.” [Anna] 
 
“And so just learning to live with it now sort of, and changing the way you do things and changing 
life and that was what the pain clinic did.  I’m learning on how to bend, walk, accept the condition” 
[Eve] 
Patients also perceived that their GPs felt supported by the clinic and that this could counteract the 
difficulties faced by patients when their GP’s knowledge base and experience was perceived as 
lacking. 
RA And what about your GP?  What’s his opinion of you being on the medication? 
Lucy: He’s okay with it as long as he can get the right support to keep the permits up which he 
wasn’t getting; he wasn’t getting any answers from the [Hospital name]. .........“He’s like 
“Well, how much do we put you on?  What do we do?”  He’s had to ring up people and get 
advice and I can’t believe it but he actually went home one night and did two hours worth of 
research on the internet and so I’ve got a good doctor.  So he knew what he was doing 
dealing with my burns so he’s been sort of flying blind…. [Lucy] 
 
In contrast to these experiences of good support, many accounts highlighted a lack of medical 
support in relation to pain management and opioid medication. Lack of knowledge about opioids was 
described in terms of their GPs ‘being out of their depth’, ‘doesn’t know which way to go’, or 
‘completely unaware of pain management’.  
The example below illustrates how such comments were usually qualified with appreciation of the 
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individual doctor’s efforts or with the constraints of the system that they were working in.  
 
Ben: but the GP’s are completely unaware of pain management I think.  Um I think that they’re, I 
think that they’re, I, I shouldn’t have been allowed to have gone for so many years in the 
state I was, you know and it wasn’t for, for, for shyness, I, they knew about it, I, I wasn’t 
sitting at home complaining to myself. 
RA: Do you feel like there just hasn’t been enough support from your GP? 
Ben: Oh it’s not just my GP, the difficulty with the GP’s these days is that it’s very difficult to see a 
regular GP so the, the, there’s rarely consistency in the medical profession you know, and 
that’s more so as it becomes more and more um overwhelmed with, with the public you 
know in [place name] you can wait weeks if you want to see a particular GP and and you 
know my one that I like I, I will wait upwards of a month to see so ah, so when you’re in pain 
and you need something more instantly you have a tendency to just take anyone they’ve 
got, so, and I don’t think there’s a crossover, I don’t think there’s a crossover of information 
between the various people and the ones that I was seeing certainly weren’t um supportive 
that way no, no. 
 
Many people felt let down by the organisation of health services for people with chronic pain, 
especially in relation to waits of up to12 months after referral to the pain clinic  – periods when all else 
had failed and their pain and medication were poorly controlled 
 
2. Medical explanation or solutions 
 
Many patients perceived their doctors to lack satisfactory explanations for their own individual illness 
or experience – a phenomenon that often disrupted the doctor-patient relationship and frustrated 
patient’s attempts to ameliorate symptoms using non-opioid approaches.  
“He hasn’t got a clue.  He - he didn’t really have a clue how to treat me, because chronic pain is 
sort of something I don’t think he’s probably ever had before too, had to deal with.  Yeah.  So, he 
was pretty useless in that regard.  I mean, he tried everything, you know.  He sent me to, um, like, 
heaps of investigations, from X-rays to, you know, MRI or whatever, but, um, bottom line is, who 
knows what causes the problem, I suppose.” [Andrew] 
 
The data also suggests that patients perceived that doctors were themselves sometimes hampered 
by the inability of their professional theories and knowledge to provide an explanation and effective 
treatment. Patients perceived two consequences of this. Firstly, this uncertainty was often seen to be 
linked with being started on opioids, as described above, and secondly, these doctors often 
transmitted, or added to, a profound sense of hopelessness.  
She (rheumatologist) couldn’t help me any more yeah, she didn’t know what else to do. She said 
to me; oh go and listen to music, I can’t do anything else for you, go and listen to some music that 
you like and I’ll refer you to the pain management.[Ella] 
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“He’s, I think, pretty much at a lost end, he’s quite a young doctor and he’s bounced me to every 
single person I think he can think of, and he hasn’t had any answers so he just writes scripts. [Max] 
 
All three patients who had been diagnosed as having fibromyalgia – a diagnosis they experienced as 
unsatisfactory as an explanation or a guide to treatment – had narratives that remained in the chaos 
category. In addition, several participants described how a sense of hopelessness, coupled with 
severe pain, led to suicidal ideas or attempts: 
 
I can handle the pain I’m in now. It’s yes – I can handle it. Whereas before, it was just – I, I couldn’t 
handle it anymore. Um and if I didn’t have kids, I probably would have killed myself knowing that – 
you know, this is the second spinal surgery I’ve had and I’m just sick of being in really, really bad pain, 
and it’s depressing. I’m on anti-depressants now. I’ve been on them for about two months now 
because I just – sometimes I, I just can’t see the light at the end of the tunnel. It’s like I’m stuck in a 
rut, no one knows what’s happening, no one can tell me what’s going to happen. We just have to wait 
[Kath] 
 
I have overdosed before, that was the one thing I haven’t mentioned to you before, and it hasn’t been 
the first time, in the past had, it’s overwhelmed me, and I think that’s something that people need to 
be aware of because chronic pain can, it can overwhelm you, and being on medication all the time it 
does overwhelm you, and it does get the better of you, and unless you have a really good 
psychologist that you’re seeing constantly, maybe not constantly, I mean I see her now every six 
weeks [Susan] 
 
3.  Social support and responsibilities 
Half of the participants spoke of the importance of being well supported, emotionally and physically, 
by their family – support that helped them to deal with the pain, the medication, and physical 
disabilities associated with their condition and/or with the adverse effects of medication. Claire, who 
had in the past taken an intentional overdose on more than one occasion, describes her partner’s 
support: 
And at the end, my partner says – we sat down there and he goes “Stay on them.” He goes, he goes 
“If you’re on them, yes they’re addictive, but he goes you’re not trying to kill yourself.” So he goes “We 
look at that point. He goes I don’t want you dead, and he goes “So we stay on them. When it comes 
to the time when we get a – the doctor or whoever, and we decide that we have to take you off them, 
we will all hold you and support you as you go down”. He goes “But right now, just stay. Do – you 
need to protect your body right now.” “Okay”, because everything I’ve done, I’ve always spoke to my 
partner, and if he’s been unsure – we’ve both been unsure, we’ve both gone into the doctor together 
to ask questions.(Claire). 
 
Eve indicated that her family’s support helped her gain control of her pain and her opioids: 
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Yeah, thank god they do live here sometimes.  They do a lot, they do the floors and the lawns and 
all that sort of thing for me.  I think if you’ve got someone to help you do these jobs you also lessen 
your medication. [Eve] 
 
However several participants noted the conflict between the caring role and a need to be bringing in a 
wage.  
“I am very much housebound, I can’t get out by myself, somebody has to be with me and push me 
in the wheelchair. My husband, he is very, very good to me, he takes me out when he can but he 
has to work because we can’t survive otherwise. My daughters all work.” [Sophie] 
 
Participants who lived alone without close family were sometimes supported by friends or workmates 
and several people described how they actively sought social involvement in voluntary activities or 
support groups. 
 
In contrast to these instances of social support, some participants described being isolated or having 
caring responsibilities that added extra work and anxiety and a need for increased medication. 
Several people described the isolating effect of not being able to continue their paid work, or the 
difficulties of working when on high dos  opioids.  
“ I mean I lost my mother, um I lost my partner, um it all happened in such a short space of a 
couple of years you know” [Chris] 
 
“I get tired and that but that’s looking after mum too, it’s a twenty four hour thing, you know, looking 
after someone” [Anna] 
 
“Definitely my life’s changed, but that’s because I’m not, not getting out and I’m not working and 
that sort of thing.”[Tom] 
 
Dealing with caring responsibilities without support sometimes had adverse effects on opioid use. 
Max, a single parent with a teenage son, describes his experience:  
“that was a big day me being in the city by nine o’clock, and then waiting in court until eventually 
he, get your named called and all that, well we didn’t get home until four o’clock that afternoon, so 
I’d gone through probably 80mg of Oxycontin and about 20mg of Valium and that was just to go 
from when I got up in the morning until I got home at four o’clock  …… like your back doesn’t care 
if you’ve got things to do.” [Max] 
 
A lack of social support sometimes limited attendance for pain management and treatment: 
“And yes, I would like to be able to to do an eight-week course or something like that. But it’s just 
not viable. Not with Kinder and my kids don’t – I’ve never put them into childcare. Um if I’ve got an 
appointment or something, someone usually will take a day off work. But my sister’s just started 
working…” [Kath] 
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Financial worries also limited the activities of several participants, some of whom described being 
were pressurised to return to work when they were not fit, or their struggles to live on benefits such as 
Newstart which ‘is a pittance - I can’t afford to live on it’.  
 
4.  The use of non-pharmaceutical interventions and self-help strategies 
Surgical operations were a common feature of these accounts and, as might be expected in stories of 
chronic pain, generally failed to improve the situation. However, two participants described how the 
pain clinic referred them for specialist surgical interventions that relieved their pain, at least for a 
period of time. Susan had a deep brain stimulator implanted which relieved pain for six months until it 
‘broke’ and Rose had a successful operation on her neck which dramatically reduced her pain and 
allowed her to stop her opioid medication. 
A more common characteristic of narratives that progressed to restitution or quests was the use of a 
variety of complementary therapies and self-help strategies: 
 
Yeah, meditation.  I’m quite fond of that.  I just do it myself.  I had some help, sorry, when I was in 
hospital; I was seeing a psychologist and he was fantastic... …I haven’t listened to it for a while, but 
it’s, it makes you think about taking your thoughts away from the pain and focusing on 
something.[Ruby] 
 
I try to you know, keep on with my activities, you know, try to lose weight, and hydro, physio, and all. 
So I’m doing that at the moment. So at least three times a week. And so it’s like, um, yes, it’s kind of 
the situation here.[Liam] 
 
I try to keep myself busy during the day, I knit at night-time and I do beading, beadwork during the day 
and china painting. I find things to be creative and keep me looking forward to the next day and the 
next day.[Sophie] 
 
Chris described how his Buddhist faith and meditation had led to a more positive mindset and regular 
exercise sessions at the gym. This had a positive effect on his pain management: 
I just went to my temple one day and started to get more interested in my, my beliefs and I no longer 
take pain killers, no longer take um sleeping pills so, but my pain is greatly reduced definitely,[Chris] 
 
There were, however, a number of barriers to accessing complementary therapies. Tom had used 
chiropractic in the past but explained how he was now frightened of making his unexplained back pain 
worse: 
 
Tom: but the thing is I just don’t know when it’s going to flare up again.  It could flare up tomorrow 
or it might not flare up for, you know – so.. 
RA That must be worrying, though, not knowing where you’re going to be the next day. 
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Tom Yeah, well, it is, because I don’t know what I can or can’t do and I haven’t seen the MRI 
results so I don’t know what sort of damage there is and what risks I’m taking if I do do, you 
know, certain activities.  I could really hurt myself, I don’t know 
 
Susan had found a chiropracter who helped her reduce her opioids but later explained that she was 
unable to continue regular treatment because of financial constraints 
So I stopped the acupuncture and the physio and ended up going to a chiropractor and I was always 
scared of a chiropractor because I thought nerves and I knew I couldn’t take any more pain from what 
I had already and this chiropractor was referred from someone that had broken his back and had 
nerve pain as well so I thought I’d give this new guy a...and he does newborns.  So I thought I’ll give 
him a go and I dropped my Oxycontin by half by going to the chiropractor. [Susan] 
 
DISCUSSION 
Our interviewees had a wide variety of experiences of taking opioids for non-cancer pain and these 
diverse accounts – chaos, restitution and quest narratives- raise questions about why and how some 
people taking opioids for chronic pain find a way forward, whilst others appear to remain in states of 
uncontrolled pain and escalating or chaotic opioid use and side effects. Our analysis has identified 
four concepts that are key influences on this variability in illness trajectory: support from individual 
health professionals and the health system; medical explanation or solutions; social support and 
social responsibilities; and the use of non-pharmaceutical interventions and self-help strategies. 
These four influences were rooted in the provisions made by society for caring for this patient group 
and involved relationships between patient and provider, between patients and their social world, and 
between different providers and their professional knowledge. The roles played by these four factors 
in making life on opioids and chronic pain more bearable and in moving experiences forward from 
uncontrolled pain and chaos towards hopefulness, stability or transformation were complex with no 
one concept acting as a single defining factor. Together, however, they construct a deeper 
understanding and encompass a range of potential interventions. 
 
In terms of study limitations, the connection between this study and a trial looking at helping people 
reduce their opioids will inevitably have affected both the study sample and the focus of our enquiry. 
We sought to minimise this by a sampling strategy that included patients who had and hadn’t agreed 
to participate in an opioid reduction trial or who had not been approached for the trial and by working 
reflexively as a group of researchers from different backgrounds. Other limitations include the lack of 
young participants (the youngest was 29); a predominantly white Australian sample; and a lack of 
resources to interview providers as well as patients. The lack of accounts of misuse or diversion of 
opioids does not mean that these phenomena do not happen – a different methodology would be 
needed to reach this group. However what we have accessed are the struggles of patients using 
opioids legitimately for the relief of severe chronic pain and we believe that the implications in terms of 
their health care needs may be transferable within Australia and to other countries.  
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In terms of the first of the four key influences, medical support, participants valued a sound knowledge 
base about opioid medication and pain management; good communication skills; and the 
maintenance of hope. They appreciated non-judgemental relationships within which explanations, 
information and guidance about opioids could be discussed and decision making could be shared - a 
finding that is consistent with a qualitative study on patients’ view of pain management at the primary 
care level
(19)
. Many of the accounts described an unmet desire and need for knowledgeable support, 
although participants qualified these criticisms with appreciation that primary care providers 
themselves required more support from specialist clinics. This finding parallels the perspectives from 
focus groups of providers whose concerns about prescribing opioids included inadequate training of 
providers and potential harm from adverse effects.
(7)
 and suggests that the professional focus on 
concerns about overuse and diversion 
(20)
 may be interfering with good doctor-patient communication 
in this area. It is difficult for doctors to avoid hopelessness if they themselves are unsupported. The 
provision of more accessible pain management clinics and good communication between them and 
general practitioners and hospital doctors has also been emphasised elsewhere.
(6, 21)
. 
 
The second key influence, a lack of convincing medical explanation or solutions, engendered 
uncertainty and hopelessness in participants, and possibly their doctors, and often disrupted the 
doctor-patient relationship. The uncertainty and fear of doing harm also frustrated patient’s attempts 
to ameliorate symptoms using non-pharmaceutical approaches. These patients found considerable 
solace in attending the pain clinic where they felt less alone and had access to a multidisciplinary 
team. The third influence we identified – the use of non-pharmaceutical interventions, both 
conventional and non-conventional - was key to some patients finding a way forward in terms of pain 
control and opioid reduction. Sometimes these interventions – surgery, meditation, physiotherapy - 
were accessed through the pain clinic. More often participants sought such help independently and 
were then at risk of frustration and disappointment when they couldn’t afford to continue treatment 
regularly. Self-help strategies were common and wide-ranging and appeared to play an important role 
in stories of adaptation, coping and transformation.  
 
Many of these narratives spanned a decade or more of people’s lives and our fourth key influence -
emotional and physical support from family and friends -  helped participants deal with the pain, the 
medication, and physical disabilities associated with their condition and/or with the adverse effects of 
medication. A lack of such support, social isolation, and/or a heavy burden of caring for dependents 
were all perceived as important influences on pain and opioid use but it appears that they were often 
not shared with their doctors thereby missing opportunities for potential interventions such as 
additional input from social work and community resources, or links to local or on-line support groups 
for people in chronic pain. Our interviews show that effective support, even when coming years after 
the pain journey has started, could still be of great benefit.  
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All four of the concepts we identified linked to the importance of maintaining and building hope.  In 
terms of recovery from illness, hope has been identified as an important coping mechanism and as 
providing the motivation to undertake actions to facilitate recovery.
(22)
 Struggles between hope and 
despair were central to narratives of people with chronic low back pain
(23)
 wherein hope was 
expressed in terms of adjustment of priorities and finding alternative meanings in life – issues very 
central to the restitution and quest narratives in our study. Other studies
(22, 24)
 note the desirability of 
healthcare professionals attending to patients’ needs for hope and the importance of discussing the 
meaning of hope with individuals. Although we did not explore this directly in our interviews, our 
findings suggest that it would be a fruitful focus for future research in this patient group.  
 
 
CONCLUSIONS  
The four key factors influencing the progress of people taking opioids for chronic non-cancer pain 
are rooted in the provisions made by society for caring for this patient group and involve relationships 
between patient and provider, between patients and their social world, and between different 
providers and their professional knowledge. In our patient sample, effective support involved the 
provision and maintenance of hope, and professionals who are knowledgeable about opioids and 
chronic pain, good communicators, and cognisant with their patients’ social support and 
responsibilities. 
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Titles of tables and figures  
 
Table 1 Characteristics of participants 
 
Figure 1 Journey of William (an example of chaos) 
Note: William is now 49yrs old. Eleven years ago he fractured three vertebrae in a fall at work and 
during a 9 month period in hospital was told he would never walk again. Two years after his surgery 
he did resume walking but he remained in severe pain which over the years was associated with two 
suicide attempts. His GP prescribed increasing amounts of opiates (and also sedatives and anti-
depressants at times) which were associated with drowsiness, poor concentration and led to 
accidents in his part-time job. He described himself as angry and frustrated because all of his life and 
relationships are affected. He did not find the pain management clinic helpful but does reduce his 
dose of opiates temporarily at times. 
 
 
Figure 2 Journey of Liam (an example of restitution)  
Note: When Liam was 19 he fell and injured his back and two years later had surgery with a good 
result. He took opioids for a month or two around the time of the operation. However, six years later 
his severe back and leg pain recurred and this time surgery was less successful so that he continued 
to get severe recurrences of his pain despite being on opioids. With the help of the pain management 
clinic and his GP he reduced and stopped his strong opioids on two occasions but each time the 
unexplained recurrence of symptoms led to hospital admissions, problems walking and a return to 
opioids. Opioids made him tired, forgetful and constipated and he was unable to work. He is now 29 
years old and has begun to feel more in charge of his opioid reduction and is continuing his 
hydrotherapy, improving his diet and doing training course on-line. 
 
 
Figure 3 Journey of Ruby (an example of quest)  
Note: Ruby has had diabetes since she was six and is now 40 years old. Four years ago her recurrent 
diabetic ulcers worsened and a 14 month spell in hospital resulted in bilateral lower leg amputations. 
In hospital she was started on high dose opioids which gave rise to severe hallucinations and when 
she was discharged to live with her supportive mother she continued to suffer from ‘clouded’ thinking, 
drowsiness and headaches. She said ‘my identity was, like, in a cupboard and I was this person that 
was looked after by everybody’. She values her relationship with the doctors at the pain management 
clinic and has slowly reduced her medication, despite severe phantom pains and pains in her stumps. 
She is now less drowsy and more confident and aims to stop opiates completely if possible. 
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Table 1. Characteristics of participants 
Psuedonym Gender 
 
Trial 
participati
on  
Ag
e 
health problem 
OM and dosage (daily) at 
interview  
Years in pain and 
Years in OM (initial 
OM)  
who initiated 
opioids 
narrative 
category 
Ella  Female Trial  58 Fibromyalgia Kapanol 100 mg  + 
tramadol 8 / 8 (OxyContin)  
GP chaos 
Jack  Male Trial 64 Low back pain, lumbar disc 
problems 
Norspan 20 + Norpsan 5 
(patch) + Panadeine  
15 / 14 (OxyContin) 
GP chaos 
Sophie Female Trial  69 Systemic vasulitis, hip pain 
OxyContin 210 mg + 
Endone  
over 3 / 3 
(OxyContin + 
Endone )  
rheumatologi
st 
restitution  
William Male Trial  49 Low back pain due to 3 fractured 
lumbar vertebra due to a fall 
OxyContin 80 mg + 
Panadeine  12 / 12 (Panadine)  
acute hospital chaos 
Oliver Male Trial 66 Severe back pain OxyContin 20 mg + 
Endone (rarely)  3 / 2 (OxyContin)  
GP restitution 
Anna Female Trial 64 Knee and back pain Norspan 10 (Patch) + 
Kapanol 50 mg  16 / 14 (tramadol)  
pain clinic restitution 
Lucy Female Trial 39 Severe burns OxyContin 5 mg + Endone 
5 mg (every other day)  3 / 3 (IV morphine)  
acute hospital quest 
James Male Trial  64 Amputation, osteomyelitis,  Kapanol 90 mg  13 / 13 (morphine) acute hospital quest 
Ruby Female Non-trial 44 Amputations, diabetic ulcers  OxyContin 5 mg + Endone 
5 mg (rarely) 
4 / 4 (OxyCcontin + 
endnone)  
acute hospital quest 
Liam Male Trial 29 Low back pain, lumbar disc 
problems 
Norspan 5 (patch) + 
Endone 5 mg  
3 /3 (Norspan + 
Endone)  
acute hospital restitution 
Max Male Trial  38 Low back pain following accident 
OxyContin 35 mg  
4 / 4 (OxyContin + 
Panadeine Fort) 
GP chaos 
Thomas Male Non-trial  53 Spinal pain, pneumothorax OxyContin 20 mg + 
Endone  5 / 5 (OxyContin)  
acute hospital chaos 
Eve Female Non-trial 44 Neck pain, cervical disc problems Oxycontin 40 mg + 
Endone  4 / 3 (tramadol) 
GP quest 
Andrew Male Trial 55 Fibromyalgia 
Oxycontin 30 + Endone  
3 / 3 (Panadeine 
forte)  
GP chaos 
Ben Male Non-trial  46 Low back pain,  lumbar disc 
problem, shoulder pain tramadol 150 mg  4 / 4 (tramadol)  
GP quest 
Rose Female Non-trial  50 Neck pain, cervical spine 
problems Mersyndol + Panadeine  
34 / 6 (Mersyndol + 
Panadeine)  
GP quest 
Chris Male Trial 77 Spinal fractures, osteoporosis 
Norspan 20 (patch)  
over 3 / over 3  
(Pethidine Injection)  
acute hospital quest 
Claire Female Trial 50 Fibromyalgia Patch 20 microgram  16 / 13 (Panadeine) GP chaos 
Susan Female Non-trial  47 Facial pain, neuralgia from root 
canal filling 
Kapanol 60 mg  + Ordine 
(prn)  19 / 19 (Panadine)  
GP restitution 
Kath Female Non-trial  35 Low back pain, lumbar disc 
problems 
Norspan 20 + Norspan 10 
(patch) + Endone  6 / 6 (Tramadol)  
GP chaos 
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Journey of William (an example of chaos)  
Note: William is now 49yrs old. Eleven years ago he fractured three vertebrae in a fall at work and during a 
9 month period in hospital was told he would never walk again. Two years after his surgery he did resume 
walking but he remained in severe pain which over the years was associated with two suicide attempts. His 
GP prescribed increasing amounts of opiates (and also sedatives and anti-depressants at times) which were 
associated with drowsiness, poor concentration and led to accidents in his part-time job. He described 
himself as angry and frustrated because all of his life and relationships are affected. He did not find the pain 
management clinic helpful but does reduce his dose of opiates temporarily at times.  
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Journey of Liam (an example of restitution)  
Note: When Liam was 19 he fell and injured his back and two years later had surgery with a good result. He 
took opioids for a month or two around th  time of the operation. However, six years later his severe back 
and leg pain recurred and this time surgery was less successful so that he continued to get severe 
recurrences of his pain despite being on opioids. With the help of the pain management clinic and his GP he 
reduced and stopped his strong opioids on two occasions but each time the unexplained recurrence of 
symptoms led to hospital admissions, problems walking and a return to opioids. Opioids made him tired, 
forgetful and constipated and he was unable to work. He is now 29 years old and has begun to feel more in 
charge of his opioid reduction and is continuing his hydrotherapy, improving his diet and doing training 
course on-line.  
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Journey of Ruby (an example of quest)  
Note: Ruby has had diabetes since she was six and is now 40 years old. Four years ago her recurrent 
diabetic ulcers worsened and a 14 month spell in hospital resulted in bilateral lower leg amputations. In 
hospital she was started on high dose opioids which gave rise to severe hallucinations and when she was 
discharged to live with her supportive mother she continued to suffer from ‘clouded’ thinking, drowsiness 
and headaches. She said ‘my identity was, like, in a cupboard and I was this person that was looked after by 
everybody’. She values her relationship with the doctors at the pain management clinic and has slowly 
reduced her medication, despite severe phantom pains and pains in her stumps. She is now less drowsy and 
more confident and aims to stop opiates completely if possible.  
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Appendix Interview Questions 
 
Interview Schedules 
The interviews are semi-structured. Questions are divided into four categories: knowledge of OM, 
opinions about OM, experience of reducing OM and family history. The interviews will be conducted 
using standard open questions (in bold below) but then the flow of the conversation will run its own 
course to ensure that the interviewees viewpoints, ideas and priorities are fully explored, within the 
confines of the research questions. The more detailed questions will be reserved as prompts, and 
used at appropriate points in the interview to ensure all areas are covered by the end. 
 
Interview patients who taking OM: 
1. We are interested in your views and experiences of taking painkillers, especially the 
stronger ones that are called opioid medications. Could you start with telling me a bit about 
your pain?  Then tell me about your own experiences of taking these? (if necessary, this can 
be clarified by identifying the actual ones that the interviewee is currently taking) 
 
Knowledge of OM 
• How many opioid medications (OM) are you taking or using and what are they? 
(identify the important type of OM. In the following, XX refers to the OM concerned.) 
• When did you start to take XX? And Why? 
• Who prescribed XX? 
• Were the reasons explained to you when the doctor prescribed XX? 
• When XX was initially prescribed, did you know for how long you would be on XX? Did you 
know the potential side effects? Did you know how to cope with the side effects? 
• How often do you have XX prescribed and by whom? 
• Every time when XX was prescribed, did the doctor explain to you any side effects? Or did the 
doctor ask you about your use of XX? 
• Have you tried different opioid medications before? 
• Where do you get information about XX and other opioid medications from? 
 
Opinions and experience about OM 
• What were your initial thoughts when XX was prescribed for you? 
• Have your thoughts or understanding about OM changed since? 
• What is your experience of taking XX and other opioid medications? Say is XX effective for 
your pain? Do you have any problems with it? 
• Do you have any side effects and how do you cope with them? 
• Are you happy to continue using XX? 
• Do you tell your friends or family about your use of XX? 
• If you do, what is their reaction? 
• Do you see any other health professionals apart from doctors? 
• Do you tell them you are taking XX? 
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• What is their reaction to XX? Does that affect you? 
• Do you know anyone else who is in pain and taking opioid medications? Do you communicate with 
each other? 
• What is the commonest theme of your communication related to your pain and opioid medications? 
• What is your GP and pain specialists’ opioin about the OM?   
 
About family history 
• Do you have any family member who have taken or are taking opioid medications? Why? 
• Do you have any family member who suffers from chronic pain? How do they cope? 
 
Opinions and experience about OM dosage  
• Do you think the dosage is adequate?  
• Do you want to increase or reduce XX? Why? 
• Have you tried to increase or reduce XX or other opioid medications before? How did you do it? Was 
it successful? What is the biggest difficulty when you tried to reduce these medications? 
 
Knowledge about referral.  
• How did you come to the pain clinic?  
• Why have you been referred?  
 
Open end question 
• Do you have anything you would like to add? 
 
End of questions 
Check that they are still happy about it having been recorded 
Thank you very much for your time and for sharing with me your thoughts! 
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